Despite the fact that Bexsero, a meningitis vaccine, is not approved for use in the United States, it will be imported to try to stop an outbreak of the disease at Princeton University, according to federal health officials. The vaccine already has been approved for use in Europe and Australia.
Bexsero, made by Swiss drugmaker Novartis, is designed to protect against a strain of the disease, serogroup B, that is not as common in the United States as it is in other parts of the world, says Barbara Reynolds, a spokeswoman for the Centers for Disease Control and Prevention. Read the full story